📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
154,243
All-time analysed
44,385
Positive
6,858
Negative
94,004
Neutral
8,928
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
28 announcements match the current filters (relevance ≥ 5).
Jyothy Labs Q4 Revenue Up 7.7% to ₹717 Cr; Strong 10.8% Volume Growth
Jyothy Labs reported a robust 10.8% volume growth in Q4 FY26, significantly outperforming its value growth of 7.7% as revenue reached ₹717 crore. While the Fabric Care and Personal Care segments saw double-digit growth, EBITDA margins for the quarter compressed to 13.5% due to rising input costs and crude-linked inflation. For the full year FY26, the company recorded a revenue of ₹2,944 crore and a PAT of ₹333.2 crore. The company remains debt-free and has recommended a final dividend of ₹3.5 per share.
Key Highlights
Q4 FY26 volume growth stood at 10.8% vs value growth of 7.7%, indicating aggressive market share pursuit.
Fabric Care segment delivered exceptional performance with 17.8% volume growth in Q4 FY26.
Personal Care segment revenue surged 20.1% in Q4, aided by GST rate reductions and a Margo brand relaunch.
Operating EBITDA margin for Q4 was 13.5%, impacted by West Asia developments and input cost inflation.
The Board recommended a final dividend of ₹3.5 per share for the financial year ended March 31, 2026.
👀 What to Watch
Investors should focus on the strong volume recovery which indicates brand strength, while monitoring the company's ability to pass on input cost hikes to protect margins in FY27. The stock remains a solid defensive play given its debt-free status and consistent dividend payout.
Jyothy Labs Recommends ₹3.50 Dividend; FY26 Net Profit Declines to ₹333.19 Crore
Jyothy Labs Limited has announced a final dividend of ₹3.50 per share for FY 2025-26, with the record date fixed as June 29, 2026. For the full financial year, the company reported a modest revenue growth of 3.5% reaching ₹2,944.29 crore, though net profit declined by 10.2% to ₹333.19 crore compared to the previous year. The fourth quarter saw a revenue increase to ₹717.41 crore, but profitability remained under pressure with a year-on-year profit dip of 12.3%.
Key Highlights
Recommended a final dividend of ₹3.50 per equity share of face value ₹1 each.
Annual revenue from operations increased to ₹2,944.29 crore in FY26 from ₹2,843.92 crore in FY25.
Net profit for FY26 decreased to ₹333.19 crore compared to ₹371.17 crore in the previous fiscal.
Q4 FY26 revenue grew 7.7% YoY to ₹717.41 crore, while Q4 net profit fell to ₹67.52 crore.
Record date for dividend entitlement is June 29, 2026, with payment scheduled on or after July 14, 2026.
👀 What to Watch
Investors should monitor the company's margin performance as profitability has declined despite revenue growth. The ₹3.50 dividend provides a decent yield, but the contraction in annual EPS from ₹10.11 to ₹9.07 warrants a cautious outlook on cost management.
Jyothy Labs Recommends Rs 3.50 Dividend; FY26 Net Profit Declines 10.2% to Rs 333 Crore
Jyothy Labs has recommended a final dividend of Rs 3.50 per share for FY 2025-26, with a record date set for June 29, 2026. While the company achieved a modest 3.5% growth in annual revenue to Rs 2,944 crore, the full-year net profit declined by 10.2% to Rs 333.2 crore. For the final quarter (Q4FY26), revenue grew 7.7% YoY, but net profit fell 12.3% to Rs 67.5 crore due to higher material costs and tax adjustments. The dividend payout remains a key positive for shareholders despite the earnings pressure.
Key Highlights
Recommended a final dividend of Rs 3.50 per equity share of face value Re 1 for FY 2025-26.
Annual revenue from operations increased by 3.5% YoY to Rs 2,94,429 Lakhs.
Full-year net profit decreased to Rs 33,319 Lakhs from Rs 37,117 Lakhs in the previous fiscal year.
Q4 FY26 net profit stood at Rs 6,752 Lakhs, a decline of 12.3% compared to Rs 7,700 Lakhs in Q4 FY25.
Record date for dividend entitlement is June 29, 2026, with payment scheduled on or after July 14, 2026.
👀 What to Watch
Investors should monitor the margin compression as material costs rose significantly despite revenue growth. While the dividend yield is attractive, the decline in EPS from Rs 10.11 to Rs 9.07 warrants a cautious approach regarding bottom-line recovery.
Jyothy Labs FY26 Net Profit Declines 10.2% to ₹333 Cr; Final Dividend of ₹3.50 Declared
Jyothy Labs reported a mixed performance for the financial year ended March 31, 2026, with annual revenue growing 3.5% YoY to ₹2,944 crore. However, net profit for the full year saw a 10.2% decline to ₹333 crore, primarily due to rising material costs and higher tax expenses. For the final quarter (Q4FY26), revenue grew 7.7% YoY, but profitability was hit by a tax adjustment of ₹10.64 crore related to earlier periods. Despite the profit dip, the board has recommended a final dividend of ₹3.50 per share.
Key Highlights
Annual Revenue from operations increased 3.5% YoY to ₹2,94,429 Lakhs in FY26.
Full-year Net Profit fell 10.2% to ₹33,319 Lakhs from ₹37,117 Lakhs in the previous year.
Q4FY26 Net Profit declined 12.3% YoY to ₹6,752 Lakhs, impacted by higher material costs and tax adjustments.
Board recommended a final dividend of ₹3.50 per equity share (350% of face value) with a record date of June 29, 2026.
Cost of materials consumed rose 8.3% for the full year, putting pressure on operating margins.
👀 What to Watch
Investors should be cautious regarding the margin pressure caused by rising input costs, though the steady dividend provides some yield support. Monitor the company's volume growth and pricing power in upcoming quarters to see if profitability stabilizes.
Jyothy Labs Q3 FY26: Revenue Up 5.1% to ₹740 Cr; Volume Growth Strong at 7.2%
Jyothy Labs reported a 5.1% YoY revenue growth to ₹740 crores for Q3 FY26, supported by a healthy 7.2% volume growth. While Fabric Care and Personal Care segments performed well, the Dishwash segment saw a 1.3% value decline despite 7% volume growth due to aggressive pricing and promotions. Gross margins contracted by 330 bps to 46.5% because of rising input costs like LABSA and SLES, alongside MRP reductions. The company has divested its Bangladesh JV to focus on domestic growth and expects the Household Insecticide segment to turn around by FY27.
Key Highlights
Revenue for Q3 FY26 stood at ₹740 crores with a volume growth of 7.2% and value growth of 5.1%.
Gross margin declined by 330 basis points to 46.5% due to raw material inflation and competitive pricing.
Fabric Care segment grew 9.2% in value, while Household Insecticides saw a 12.6% value growth driven by liquid vaporizers.
Dishwash segment volume grew 7% but value declined 1.3% due to higher grammage and price cuts.
Divested stake in Bangladesh JV (JKBL) with a loss of ₹4 crores to focus on core domestic and select export markets.
👀 What to Watch
Investors should focus on the company's ability to maintain volume momentum while navigating gross margin pressures from raw material volatility. The strategic shift in the Household Insecticide segment toward liquid vaporizers is a key monitorable for long-term profitability.
Jyothy Labs Q3 FY26: Revenue Up 5.1% to ₹740 Cr, Volume Growth Strong at 7.2%
Jyothy Labs reported a 5.1% YoY revenue growth for Q3 FY26, reaching ₹740 Crores, supported by a healthy volume growth of 7.2%. However, profitability faced headwinds as Gross Margins contracted to 46.5% from 49.8% due to commodity inflation and increased consumer offers. Operating EBITDA declined by 4.4% to ₹110.7 Crores, with margins dropping to 15.0% from 16.5% in the previous year. While Personal Care and Dishwashing segments grew double-digits, the Household Insecticides segment saw a marginal decline of 1.3%.
Key Highlights
Revenue from operations increased 5.1% YoY to ₹740 Crores with 7.2% volume growth.
Gross Margin contracted by 330 basis points to 46.5% due to inflationary commodity trends.
PAT for the quarter stood at ₹81.1 Crores, representing a 7.2% decline compared to the same period last year.
Personal Care segment led growth at 12.6%, followed by Dishwashing at 10.9% and Fabric Care at 9.2%.
Direct reach maintained at 1.3 million outlets with total availability across 3.6 million outlets pan-India.
👀 What to Watch
Investors should monitor the company's margin recovery trajectory as it balances volume growth with commodity price pressures. While the volume-led growth is a positive sign of brand strength, the contraction in EBITDA margins requires a cautious outlook until price-cost parity is restored.
Jyothy Labs Q3 Results: Revenue Up 5.1% to ₹740 Cr with 7.2% Volume Growth
Jyothy Labs reported a steady performance for Q3 FY26, with revenue reaching ₹740 crore, supported by a robust 7.2% volume growth. While value growth stood at 5.1% due to pricing pressures in the Dishwash segment, the company maintained a healthy operating EBITDA margin of 15%. Strong double-digit growth was observed in Household Insecticides (12.6%) and Personal Care (10.9%), while Fabric Care grew by 9.2%. Management highlighted a recovery in General Trade and continued strength in E-commerce and Quick Commerce channels.
Key Highlights
Net Revenue for Q3 FY26 reached ₹740 crore, marking a 5.1% YoY value growth.
Volume growth outperformed value growth at 7.2%, indicating strong consumer demand.
Operating EBITDA stood at ₹110.7 crore with a margin of 15% for the quarter.
Household Insecticides and Personal Care segments grew by 12.6% and 10.9% in value respectively.
Dishwash segment saw 7% volume growth despite a 1.3% value decline due to strategic price cuts.
👀 What to Watch
Investors should take confidence in the strong volume growth and recovery in General Trade, which suggests market share gains. Monitor the company's ability to improve value growth as pricing stabilizes in the coming quarters.
Jyothy Labs Q3 Net Profit Dips 7.2% YoY to ₹81.1 Cr; Revenue Up 5.1%
Jyothy Labs reported a modest 5.1% YoY increase in revenue to ₹739.61 crore for the quarter ended December 31, 2025. However, net profit declined by 7.2% YoY to ₹81.12 crore, primarily due to higher material costs and margin pressure in core segments like Fabric Care and Dishwashing. A notable positive was the Household Insecticides segment, which significantly narrowed its losses to ₹0.27 crore from ₹10.21 crore in the previous year. Overall, the results reflect a challenging quarter with rising expenses offsetting revenue gains.
Key Highlights
Revenue from operations grew 5.1% YoY to ₹739.61 crore compared to ₹703.71 crore in Q3 FY25.
Net profit for the quarter fell 7.2% YoY to ₹81.12 crore, down from ₹87.41 crore.
Fabric Care segment revenue rose to ₹350.93 crore, but segment profit decreased to ₹67.71 crore from ₹71.58 crore YoY.
Household Insecticides segment showed recovery, reducing losses to ₹0.27 crore from a loss of ₹10.21 crore YoY.
Total expenses increased to ₹645.50 crore, driven by higher cost of materials consumed at ₹353.52 crore.
👀 What to Watch
Investors should be cautious as the profit decline indicates margin pressure despite revenue growth. Monitor the company's ability to manage raw material costs and the continued turnaround in the Household Insecticides business.
